Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Assets (2019 - 2025)

Historic Assets for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $1.1 billion.

  • IDEAYA Biosciences' Assets fell 131.37% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year decrease of 131.37%. This contributed to the annual value of $1.1 billion for FY2025, which is 131.37% down from last year.
  • IDEAYA Biosciences' Assets amounted to $1.1 billion in Q4 2025, which was down 131.37% from $1.2 billion recorded in Q3 2025.
  • IDEAYA Biosciences' 5-year Assets high stood at $1.2 billion for Q3 2024, and its period low was $326.1 million during Q1 2021.
  • For the 5-year period, IDEAYA Biosciences' Assets averaged around $687.1 million, with its median value being $530.2 million (2023).
  • Per our database at Business Quant, IDEAYA Biosciences' Assets soared by 22035.94% in 2021 and then tumbled by 441.47% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Assets (Quarter) stood at $381.3 million in 2021, then rose by 1.74% to $388.0 million in 2022, then skyrocketed by 67.36% to $649.3 million in 2023, then surged by 73.12% to $1.1 billion in 2024, then fell by 1.31% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, $1.2 billion for Q3 2025, and $1.0 billion during Q2 2025.